IQVIA fined $7.8 million for failing to properly anonymize health data

Why this matters: Health data is about as personal as data gets. When a company processes it at scale and fails to properly anonymize it, real people face real exposure — not just embarrassment, but potential discrimination, insurance consequences, and loss of medical privacy they never agreed to sacrifice. IQVIA is a major player in pharmaceutical data and health analytics. That makes this a systemic issue, not a one-off. The fine signals that regulators are paying attention to re-identification risk, not just obvious data leaks. Whether €7 million is enough to change how a company this size handles patient data is a separate question worth asking.